Bile Acid
[Bile Acid]
EPTIS factsheet 142639 | Last revision 2024-12-17 | URL: https://www.eptis.bam.de/pts142639 https://www.eptis.bam.de/pts142639
| PT provider | |||||||||||||
| PT provider | Weqas Weqas | ||||||||||||
| Based in | United Kingdom | ||||||||||||
| Language(s) | |||||||||||||
| Remarks | Three liquid human serum samples covering an appropriate range for the diagnosis and monitoring of Cholestasis in Pregnancy. A linear series of up to 9 pools are prepared in serum containing a mixture of Cholic acid and Deoxycholic acid, the ratio of which reflects both physiological levels and pathological levels observed in ICP. Target values for both Cholic acid and Chenodeoxycholic acid are assayed using a ID – GC Mass Spectrometer for each sample. The programme is designed to assess laboratory and method performance, including bias, within and between batch imprecision, linearity, trueness, sensitivity and specificity of TSBA. Key Features: Linear panels assigned by a higher meteorological order reference method. Panel of liquid human serum samples covering an appropriate range and BA ratio for the diagnosis and monitoring of ICP Challenging samples containing UDCA and other BA to determine specificity. Analytical performance Specification based on Milan Model 3. For more information: https://www.weqas.com/services/eqa/bileacid/ or contact@weqas.com | ||||||||||||
| Keywords | |||||||||||||
| Product groups |
Health care / medical devices
|
||||||||||||
| Testing fields |
Medical analysis
|
||||||||||||
| Technical details | |||||||||||||
|
|||||||||||||
| Aims of the PT scheme | |||||||||||||
| Target group of participants | Laboratory Diagnostic Services | ||||||||||||
| Linked to specific legislation / standards | Accreditation by UKAS on the basis of ISO/IEC 17043. | ||||||||||||
| Additional, subsidiary aims | validation of testing methods | ||||||||||||
| Number of participants | |||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/ IEC 17043 |
||||||||||||
| Operation is commissioned / requested by | |||||||||||||
| Fees and frequency | |||||||||||||
| Participation fee | Fee dependent on number of participating sections and proximetry of testing methods. | ||||||||||||
| Regularly operated | Yes (Frequency: Monthly. Samples: 3 x 0.5 mL) | ||||||||||||
| Year of first operation | 2004 | ||||||||||||
| Contact details of the PT provider | |||||||||||||
| Provider | Contact person | ||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Phone: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884 Fax: Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
||||||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.